Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice

Gene Therapy

Volumn 5, Issue 11, 1998, Pages 1545-1551

  Eliopoulos, N ^a   Bovenzi, V ^a   Le, N L O ^a   Momparler, L F ^a   Greenbaum, M ^b   Letourneau S ^b   Cournoyer, D ^b   Momparler, R L ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Cytidine deaminase; Cytosine arabinoside; Drug resistance; Gene transfer; Hematopoietic cells; In vivo expression

Indexed keywords

COMPLEMENTARY DNA; CYTARABINE; CYTIDINE DEAMINASE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; CANCER THERAPY; CELL TRANSPLANTATION; CHEMOPROPHYLAXIS; DRUG RESISTANCE; GENE TRANSFER; HEMATOPOIETIC CELL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SPLEEN;

ANIMALIA; ARA; MURINAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0031740014     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300767     Document Type: Article

References (30)

1. Bertino JR. 'Turning the tables' - making normal marrow resistant to chemotherapy. J Natl Cancer Inst 1990; 82: 1234-1235.
2. Hanania EG et al. Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Therapy 1995; 2: 279-284.
3. Podda S et al. Transfer and expression of the human multiple drug resistance gene into live mice. Proc NatI Acad Sci USA 1992; 89: 9676-9680.
4. Corey CA, DeSilva AD, Holland CA, Williams DA. Serial transplantation of methotrexate-resistant bone marrow: protection of murine recipients from drug toxicity by progeny of transduced stem cells. Blood 1990; 75: 337-343.
5. Zhao SC et al Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase. Cancer Gene Ther 1994; 1: 27-33.
6. Allay JA et al. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 1995; 85: 3342-3351.
7. Allay JA, Davis BM, Gerson SL. Human alkyltransferase-transduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice. Exp Hematol 1997: 25: 1069-1076.
8. Hesdorffer C et al. Human MDR gene transfer in patients with advanced cancer. Hum Gene Ther 1994; 5: 1151-1160.
9. Deisseroth AB, Holmes F, Hortobagyi G, Champlin R. Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial. Hum Gene Ther 1996; 7: 401-416.
10. O'Shaughnessy JA et ai. Retrovirus-mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. Hum Gene Ther 1994; 5: 891-911.
11. Hesdorffer C et al. Phase I trial of relrovirus-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol 1998; 16: 165-172.
12. Bouffard DY, Laliberté J, Momparler RL. Kinetic studies on 2′,2′-difluorodeoxycytidine (gemcitabine) with purified human deoxycytldine kinase and cytidine deaminase. Biochem Pharmacol 1993; 45: 1857-1861.
13. Chabot GG, Bouchard J, Momparler RL. Kinetics of deamination of 5-aza-2′-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazaururidine, thymidine or uracil arabinoside. Biochem Phamtacol 1983; 32: 1327-1328.
14. Rivard GE et al. Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia. Leukemia Res 1981; 5: 453-462.
15. Czaykowski PM, Samuels T, Oza A. A durable response to cytarabine in advanced breast cancer. Clin Oncol 1997; 9: 181-183.
16. Fossella FV et al. Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer. J Clin Oncol 1997; 15: 310-316.
17. Momparter RL et al. Pilot phase I-II study on 5-aza-2′-deoxycytidine (decitabine) in patients with metastatic lung cancer. AntiCancer Drugs 1997; 8: 358-368.
18. Laliberté J, Momparler RL. Human cytidine deaminase: purification of enzyme, cloning and expression of its complementary DNA. Cancer Res 1994; 54: 5401-5407.
19. Momparler RL et al. Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside. Anti-Cancer Drugs 1996; 7: 266-274.
20. Momparler RL et al. Resistance to cytosine arabinoside by retrovirally-mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells Cancer Gene Ther 1996; 3: 331-338.
21. Eliopoulos N et al. Gene transfer of human cytidine deaminase cDNA into murine cells confers resistance to cytosine arabinoside, 5-aza-2′-deoxycytidine and 2′,2′-difluorodeoxycytidine. 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy. Ann Oncol 1996; 7: (Suppl. 1): 58.
22. Eliopoulos N, Cournoyer D, Momparler RL. Drug resistance to 5-aza-2′-deoxycytidine, 2′,2′-difluorodeoxycytidine and cytosine arabinoside conferred by retrovirus-mediated transfer of human cytidine deaminase cDNA into murine cells. Cancer Chem Pharmacol (in press).
23. Challita P-M, Kohn DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 1994; 91: 2567-2571.
24. Zhao SC, Banerjee D, Mineishi S, Bertino JR. Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA. Hum Gene Ther 1997; 8: 903-909.
25. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plastnids. J Virol 1988; 62: 1120-1124.
26. Murphy WH, Urnovitz HB, Maryanski JL, Abrams GD. Characterization of transplantable myelomonocytic leukemia WEH1-3B in syngeneic BALB/c mice, Proc Soc Exp Biol Med 1978; 157: 556-564.
27. Hoang T, McCullough EA. Production of leukemic blast growth factor by a bladder carcinoma cell line. Blood 1985; 66: 748-751.
28. Momparler RL, Gonzales FA. Effect of intravenous infusion of 5-aza-2′-deoxycytidine on survival time of mice with L1210 leukemia. Cancer Res 1978; 38: 2673-2678.
29. Drize N et al. Long-term maintenance of hematopoiesis in irradiated mice by retrovirally transduced peripheral blood stem cells. Blood 1997; 5: 1811-1817.
30. Momparler RL, Laliberté J. Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2′-deoxycytidine. Leukemia Res 1990; 14: 751-754.